PMID: 3761234Jan 1, 1986Paper

Mediating factors in non-medical treatment for migraine headache: toward an interactional model

Journal of Psychosomatic Research
M D Litt

Abstract

The inadequacy of traditional (i.e. pharmacological) treatment for migraine headache has led to the development of numerous non-medical interventions (e.g. biofeedback, relaxation, cognitive-behavioral programs). All of these non-medical interventions have produced at least some success in reducing migraine headache parameters. However the mechanism of treatment efficacy is unclear, with a number of not mutually exclusive relationships proposed. Purported mediators of successful outcome in these treatments include specific control of vascular activity, general reduction of autonomic arousal, biochemical changes, cognitive, affective, and behavioral change, therapist contact and support, and credibility and placebo expectancy. The present paper attempts to discuss and evaluate the mechanisms of change that have been proposed as mediators of successful treatment of migraine headache. An interactional model of adaptive change as a function of treatment is presented. The implications of the model for assessment and treatment are discussed. It is suggested that the interactional model may be applicable to the treatment of a range of chronic pain problems.

References

Jun 1, 1979·Biofeedback and Self-regulation·A Nouwen, J W Solinger
May 1, 1978·Archives of General Psychiatry·E B BlanchardD A Brown
Nov 1, 1979·Psychological Bulletin·D C TurkW H Berman
Dec 1, 1977·The Journal of Nervous and Mental Disease·A Dean, N Lin
Jan 1, 1978·Headache·J M MullinixM A Fishman
Jun 1, 1978·Psychosomatic Medicine·M J CohenD L McArthur
Sep 1, 1976·Headache·F SircuteriB Anselmi
Mar 1, 1977·Headache·J L Medina, S Diamond
Apr 1, 1977·The American Journal of Clinical Hypnosis·L K Daniels
Dec 1, 1977·The American Journal of Psychiatry·J D Frank
Sep 1, 1977·Biofeedback and Self-regulation·M Feuerstein, H E Adams
Apr 1, 1976·Archives of General Psychiatry·A Turin, W G Johnson
Jul 1, 1976·Headache·J L MedinaM A Franklin
Jun 1, 1976·Biofeedback and Self-regulation·D Meichenbaum
Jul 1, 1975·The International Journal of Clinical and Experimental Hypnosis·T Andreychuk, C Skriver
Mar 1, 1975·Acta Neurologica Scandinavica·O Sjaastad
May 1, 1975·The American Psychologist·R S Lazarus
Jan 1, 1976·Headache·P S MitchA Iannone
Feb 1, 1976·Journal of Consulting and Clinical Psychology·L R Friar, J Beatty
May 1, 1974·Archives of General Psychiatry·E B Blanchard, L D Young
Nov 19, 1965·Science·R Melzack, P D Wall
Jun 1, 1971·Journal of Psychosomatic Research·K R Mitchell, D M Mitchell
Sep 1, 1980·Headache·G W Bruyn
Jan 1, 1983·Journal of Psychosomatic Research·D S Holmes, T G Burish
Jan 1, 1984·Journal of Psychosomatic Research·J G ArenaF Andrasik
Jan 1, 1984·Journal of Psychosomatic Research·P D Drummond
Mar 1, 1980·Journal of Behavioral Medicine·K A HolroydJ Noble
Jan 1, 1982·Journal of Psychosomatic Research·M FeuersteinR Corbisiero
Jan 1, 1982·Journal of Psychosomatic Research·L CoureyC Bush
Dec 1, 1982·Journal of Consulting and Clinical Psychology·G E Schwartz
Dec 1, 1981·Journal of Behavioral Medicine·J GauthierM Drolet
Feb 1, 1980·Journal of Consulting and Clinical Psychology·R Bild, H E Adams
Jun 1, 1980·Biofeedback and Self-regulation·F BorgeatC N Bedwani

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.